PL325514A1 - Addition salts formed with acids of 2,3,4,5-tetrahydro-1h-3-benzazepinic compounds - Google Patents

Addition salts formed with acids of 2,3,4,5-tetrahydro-1h-3-benzazepinic compounds

Info

Publication number
PL325514A1
PL325514A1 PL96325514A PL32551496A PL325514A1 PL 325514 A1 PL325514 A1 PL 325514A1 PL 96325514 A PL96325514 A PL 96325514A PL 32551496 A PL32551496 A PL 32551496A PL 325514 A1 PL325514 A1 PL 325514A1
Authority
PL
Poland
Prior art keywords
benzazepinic
tetrahydro
acids
compounds
addition salts
Prior art date
Application number
PL96325514A
Inventor
Louis Brammer Hansen
Rolf Emil Amsler
Scott Eugene Mcgraw
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL325514A1 publication Critical patent/PL325514A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL96325514A 1995-09-15 1996-09-12 Addition salts formed with acids of 2,3,4,5-tetrahydro-1h-3-benzazepinic compounds PL325514A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK103095 1995-09-15
PCT/DK1996/000383 WO1997010239A1 (en) 1995-09-15 1996-09-12 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds

Publications (1)

Publication Number Publication Date
PL325514A1 true PL325514A1 (en) 1998-08-03

Family

ID=8100205

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96325514A PL325514A1 (en) 1995-09-15 1996-09-12 Addition salts formed with acids of 2,3,4,5-tetrahydro-1h-3-benzazepinic compounds

Country Status (13)

Country Link
EP (1) EP0850237A1 (en)
JP (1) JPH11512403A (en)
KR (1) KR19990044648A (en)
CN (1) CN1200121A (en)
AU (1) AU700596B2 (en)
BR (1) BR9610162A (en)
CA (1) CA2231848A1 (en)
CZ (1) CZ77898A3 (en)
HU (1) HUP9900746A3 (en)
IL (1) IL123602A0 (en)
NO (1) NO981135D0 (en)
PL (1) PL325514A1 (en)
WO (1) WO1997010239A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK23392D0 (en) * 1992-02-24 1992-02-24 Novo Nordisk As Heterocyclic Compounds, Their Uses and Preparation

Also Published As

Publication number Publication date
HUP9900746A2 (en) 1999-09-28
CA2231848A1 (en) 1997-03-20
CN1200121A (en) 1998-11-25
JPH11512403A (en) 1999-10-26
BR9610162A (en) 1999-01-05
HUP9900746A3 (en) 1999-11-29
IL123602A0 (en) 1998-10-30
NO981135L (en) 1998-03-13
CZ77898A3 (en) 1998-07-15
MX9802000A (en) 1998-08-30
AU700596B2 (en) 1999-01-07
WO1997010239A1 (en) 1997-03-20
AU6923596A (en) 1997-04-01
NO981135D0 (en) 1998-03-13
KR19990044648A (en) 1999-06-25
EP0850237A1 (en) 1998-07-01

Similar Documents

Publication Publication Date Title
PL309975A1 (en) Derivatives of 2,6-diaminopurine
HU9501944D0 (en) Phosphonic acid derivatives
GB9504065D0 (en) Poly-pyrrolecarboxamidonaphthalenic acid derivatives
IL122987A0 (en) Novel 2,3-dioso-1, 2, 3, 4-tetrahydro-quinoxalinyl derivatives
HU9502684D0 (en) 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkane-carboxylic acid derivatives
GB9325558D0 (en) Percaboxylic acids
EP0845457A4 (en) 2,2-dideutero-5-aminolevulinic acid
ZA959511B (en) Solid salts of hop acids
IL121730A0 (en) Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
HK1006571A1 (en) Clavulanic acid salts
HU9400745D0 (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives
HU9503959D0 (en) Process for the preparation of substituted 4,6-diamino-5-cyanopyrimidines
EP0618222A3 (en) Dipeptid derivatives of 5-amino-4-hydroxy-hexanoic acid.
PL325514A1 (en) Addition salts formed with acids of 2,3,4,5-tetrahydro-1h-3-benzazepinic compounds
AU5635496A (en) Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-he xulofluranosonic acid
BR9408162A (en) 2,3,5,6-tetrafluorbenzoic acid derivatives
ZA974929B (en) New forms of organic salts of N'N-diacetylcystine.
HUP9901345A3 (en) Novel quinoxaline- and quinoxalinylalkane-phosphonic acids
IL118731A0 (en) Process for the preparation of 2,2-dialkyl-arylidene-cycloalkanones
GB2298201B (en) Clavulanic acid salts
IL120556A (en) Process for the preparation of 3,3,5-trichloroglutarimide
SI0726270T1 (en) Derivatives of 1,6-naphthyridone carboxylic acids
EP0587533A3 (en) Process for the preparation of alpha-aminoketone salts.
GB9325420D0 (en) 4'-o-sulfonyl-anthracycline derivatives
ZA974928B (en) Process for the preparation of organic salts of N'N-Diacetylcystine.